Nasdaq Net Change Percentage Gainers & Losers

Dow Jones04-30
GAINERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
Deciphera PharmDCPH25.2810.6372.5650,721,101
Phibro Animal HealthPAHC16.784.0531.81785,165
Direxion TSLA Bull 2XTSLL9.362.2130.9182,781,217
GrShr 2x Long TSLA DlyTSLR14.083.3130.731,477,169
T-Rex 2X Lg Tesla DlyTSLT12.783.0030.6713,127,198
Eliem TherapeuticsELYM5.021.0426.131,595,525
ImmunityBioIBRX8.991.6422.3166,003,790
GraniteSh 1.25x Lg TeslaTSL7.741.2419.15717,989
Janux TherapeuticsJANX56.088.6918.341,533,848
Acrivon TherapeuticsACRV10.001.5418.20239,271
LOSERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
GrShr 2x Sh TSLA DailyTSDD17.14-7.76-31.161,622,216
T-Rex 2X Invr Tesla DlyTSLZ27.23-12.04-30.667,692,115
Lifeway FoodsLWAY20.01-4.86-19.54647,053
Riverview BancorpRVSB3.75-0.70-15.7393,917
AXS TSLA Bear Daily ETFTSLQ32.99-5.99-15.377,603,513
Direxion Dly TSLA Br 1XTSLS21.92-3.97-15.334,452,722
GrShr 2x Long COIN DailyCONL48.78-8.72-15.171,723,609
AltimmuneALT6.40-0.87-11.914,912,481
SoFi TechnologiesSOFI7.05-0.83-10.48148,856,125
MoneyHeroMNY2.08-0.24-10.34570,507
Only includes stocks with a prior day close of $2 a share
or higher and at least 2,000 shares traded today.
Data are delayed at least 15 minutes.
Source: WSJ Market Data Group

(END) Dow Jones Newswires

April 29, 2024 17:38 ET (21:38 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment